Business Description
Medexus Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA70533E1088
Compare
Compare
Traded in other countries / regions
MDP.CanadaMEDXF.USAP731.Germany IPO Date
2017-11-02Description
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.22 | |||||
| Debt-to-Equity | 1.44 | |||||
| Debt-to-EBITDA | 2.63 | |||||
| Interest Coverage | 1.11 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.71 | |||||
| Beneish M-Score | -3.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.1 | |||||
| 3-Year EPS without NRI Growth Rate | 58.5 | |||||
| 3-Year Book Growth Rate | 12.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.05 | |||||
| 9-Day RSI | 59.55 | |||||
| 14-Day RSI | 57.84 | |||||
| 6-1 Month Momentum % | 45.88 | |||||
| 12-1 Month Momentum % | -19.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | |||||
| Quick Ratio | 0.49 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 203.41 | |||||
| Days Sales Outstanding | 72.02 | |||||
| Days Payable | 219.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.5 | |||||
| Shareholder Yield % | 24.19 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.51 | |||||
| Operating Margin % | 11.31 | |||||
| Net Margin % | 1.03 | |||||
| FCF Margin % | 20.61 | |||||
| ROE % | 4.1 | |||||
| ROA % | 0.71 | |||||
| ROIC % | 10.28 | |||||
| 3-Year ROIIC % | -286.32 | |||||
| ROC (Joel Greenblatt) % | 73.06 | |||||
| ROCE % | 14.68 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 38.7 | |||||
| Forward PE Ratio | 26.71 | |||||
| PE Ratio without NRI | 36.58 | |||||
| Price-to-Owner-Earnings | 4.65 | |||||
| PS Ratio | 0.42 | |||||
| PB Ratio | 1.46 | |||||
| Price-to-Free-Cash-Flow | 2.02 | |||||
| Price-to-Operating-Cash-Flow | 1.99 | |||||
| EV-to-EBIT | 7.04 | |||||
| EV-to-EBITDA | 4.79 | |||||
| EV-to-Forward-EBITDA | 3.13 | |||||
| EV-to-Revenue | 0.8 | |||||
| EV-to-Forward-Revenue | 0.83 | |||||
| EV-to-FCF | 3.85 | |||||
| Price-to-Projected-FCF | 1.13 | |||||
| Price-to-Median-PS-Value | 0.31 | |||||
| Earnings Yield (Greenblatt) % | 14.2 | |||||
| FCF Yield % | 46.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MEDXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medexus Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 108.782 | ||
| EPS (TTM) ($) | 0.05 | ||
| Beta | 1.98 | ||
| Volatility % | 101.45 | ||
| 14-Day RSI | 57.84 | ||
| 14-Day ATR ($) | 0.0651 | ||
| 20-Day SMA ($) | 1.8964 | ||
| 12-1 Month Momentum % | -19.01 | ||
| 52-Week Range ($) | 1.06 - 2.46 | ||
| Shares Outstanding (Mil) | 24.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medexus Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medexus Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medexus Pharmaceuticals Inc Frequently Asked Questions
What is Medexus Pharmaceuticals Inc(MEDXF)'s stock price today?
The current price of MEDXF is $1.95. The 52 week high of MEDXF is $2.46 and 52 week low is $1.06.
When is next earnings date of Medexus Pharmaceuticals Inc(MEDXF)?
The next earnings date of Medexus Pharmaceuticals Inc(MEDXF) is 2024-11-08 Est..
Does Medexus Pharmaceuticals Inc(MEDXF) pay dividends? If so, how much?
Medexus Pharmaceuticals Inc(MEDXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers